OGMS Workshop: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| (19 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Date''': Morning of July 10, 2013 | '''Date''': Morning of July 10, 2013 | ||
'''Venue''': Montreal, Quebec (co-located with ICBO 2013) | '''Start''': 9:00am | ||
'''End''': 1:00pm | |||
'''Venue''': Montreal, Quebec (co-located with ICBO 2013): Room MB 2.255 (2nd floor of MB building, next to ICBO auditorium) | |||
'''Proposed topics for discussion''' | '''Proposed topics for discussion''' | ||
*Hyperglycemia: Disorder or Disposition (Prabhu Shankar) | *9:00 Hyperglycemia: Disorder or Disposition (Prabhu Shankar) | ||
*9:30 Blocked Dispositions (Albert Goldfain) | |||
*9:45 Signs and symptoms - can we reach a consensus to treat these as roles of clinical findings? (Alexander Cox) [http://ontology.buffalo.edu/13/cox-OGMS.pptx slides] | |||
*10:30 Coffee | |||
*10:45 Conditions and situations in SNOMED - how to benefit from OGMS (Stefan Schulz) [http://ontology.buffalo.edu/13/Schulz-OGMS.pptx slides] | |||
*11:15 BFO 2.0 and Process Patterns (Barry Smith) | |||
:*What is a Disease Course? | |||
:*Disease Course Sub-Typing | |||
*11:30 Syndromes - are they patterns and, if so, what are patterns? (Alexander Cox) | |||
<u>Tentative</u> | |||
*Diagnostic guidelines - how do they relate to diagnoses, clinical findings, signs and symptoms, and more? | |||
* | *What sorts of causal relations can we assert in OGMS? | ||
'''Participants''' | '''Participants''' | ||
Sivaram Arabandi (Houston) | Sivaram Arabandi (Houston) | ||
Olivier Bodenreider (NLM) | |||
Melanie Courtot (Vancouver) | Melanie Courtot (Vancouver) | ||
Alexander Cox (Buffalo) | |||
Alexander Diehl (Buffalo) | Alexander Diehl (Buffalo) | ||
Mary Dolan (Jackson Lab) | |||
Kerstin Forsberg (AstraZeneca) | Kerstin Forsberg (AstraZeneca) | ||
| Line 26: | Line 54: | ||
Bill Hogan (Arkansas) | Bill Hogan (Arkansas) | ||
John Hughes (McGill) | |||
Andrew James (Toronto) | Andrew James (Toronto) | ||
Mark Jensen (Buffalo) | Mark Jensen (Buffalo) | ||
Kouji Kozaki (Osaka) | |||
Yu Lin (Michigan) | Yu Lin (Michigan) | ||
Snezana Nikolic (Emory University, Atlanta) | Snezana Nikolic (Emory University, Atlanta) | ||
Heiner Oberkampf (Munich) | |||
Alan Ruttenberg (Buffalo) | |||
Stefan Schulz (Graz) | |||
Prabhu Shankar (Emory University, Atlanta) | Prabhu Shankar (Emory University, Atlanta) | ||
Barry Smith (Buffalo) | Barry Smith (Buffalo) | ||
Yuki Yamagata (Osaka) | |||
Latest revision as of 17:51, 10 July 2013
Date: Morning of July 10, 2013
Start: 9:00am
End: 1:00pm
Venue: Montreal, Quebec (co-located with ICBO 2013): Room MB 2.255 (2nd floor of MB building, next to ICBO auditorium)
Proposed topics for discussion
- 9:00 Hyperglycemia: Disorder or Disposition (Prabhu Shankar)
- 9:30 Blocked Dispositions (Albert Goldfain)
- 9:45 Signs and symptoms - can we reach a consensus to treat these as roles of clinical findings? (Alexander Cox) slides
- 10:30 Coffee
- 10:45 Conditions and situations in SNOMED - how to benefit from OGMS (Stefan Schulz) slides
- 11:15 BFO 2.0 and Process Patterns (Barry Smith)
- What is a Disease Course?
- Disease Course Sub-Typing
- 11:30 Syndromes - are they patterns and, if so, what are patterns? (Alexander Cox)
Tentative
- Diagnostic guidelines - how do they relate to diagnoses, clinical findings, signs and symptoms, and more?
- What sorts of causal relations can we assert in OGMS?
Participants
Sivaram Arabandi (Houston)
Olivier Bodenreider (NLM)
Melanie Courtot (Vancouver)
Alexander Cox (Buffalo)
Alexander Diehl (Buffalo)
Mary Dolan (Jackson Lab)
Kerstin Forsberg (AstraZeneca)
Albert Goldfain (Blue Highway Inc.)
Yongqun He (Michigan)
Bill Hogan (Arkansas)
John Hughes (McGill)
Andrew James (Toronto)
Mark Jensen (Buffalo)
Kouji Kozaki (Osaka)
Yu Lin (Michigan)
Snezana Nikolic (Emory University, Atlanta)
Heiner Oberkampf (Munich)
Alan Ruttenberg (Buffalo)
Stefan Schulz (Graz)
Prabhu Shankar (Emory University, Atlanta)
Barry Smith (Buffalo)
Yuki Yamagata (Osaka)
